SINGAPORE (Aug 14): Tianjin Zhong Xin Pharmaceutical Group Corporation has recorded earnings of RMB 156.9 million ($30.8 million) or 0.20 RMB cents per share for the 2Q19 ended June, some 10% higher than earnings of RMB 142.2 million a year ago.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply